| ||
| Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for ... The Herald | HeraldOnline.com Phase 2 Study of R343, an inhaled SYK inhibitor Approximately 270 adults with allergic asthma will be randomized into the three arms of this Phase 2 clinical study of R343, called SITAR (SYK Inhibition for Treatment of Asthma with R343), for eight ... See all stories on this topic » | ||
| ||
| Child's Use of Certain Asthma Drugs Could Shorten Adult Height U.S. News & World Report All the children took albuterol, a fast-acting drug for relief of acute asthma symptoms, and oral corticosteroids as needed to treat asthma symptoms. The children were followed until they reached their full adult height -- age 18 or older for females ... See all stories on this topic » |
This once a week Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment